1.

Acute HIV Infection

2. Adjuvants
3. Animal Models
4. B Cell Immunology and Neutralizing Antibodies
5. B Cell Vaccine Concepts and Design
6. Clinical Trial Site Challenges
7. Host Genetic Factors
8. Immune Escape
9. Innate Immunity
10. Mucosal Immunity
11. Novel Immunogens/Inserts
12. Pediatric/Adolescent Infections & Trials
13. Preclinical and Clinical Therapeutic Trials
14. Preclinical and Clinical Prophylactic Vaccine Trials
15. Prevention Strategies
16. Social/Ethical/Access/Regulatory Issues
17. T Cell Immunity
18. T Cell Vaccine Concepts and Design
19. Vaccine concepts and design
20. Viral Diversity
21. Virology & Immunology of HIV Transmission
• Early Infection
• B-cell immunity – antibody response
• T-cell immunity – killer T-cells
• Innate immunity
• Early Clinical Trials
• Advanced Clinical Trials
• Interface of PreP/Microbicides and Vaccines
• Early Infection
– Plenaries:
• Ashley Haase
• Andrew McMichael
– Symposia
• Symposium 03: Animal Models of HIV Transmission
– Lifson, Picker, Watkins and Hirsch
• Symposium 04: Blocking HIV/ SIV Acquisition
– Hope, Shattock, Bomsell, Letvin, Robinson
– Oral Abstracts
• Oral Abstract 04: Acute Infection/Viral Diversity
• Oral Abstract 11: Virology and Immunology of Transmission
• B-cell immunity – antibody response
– Plenaries:
• John Mascola
• Julie Overbaugh
– Symposia
• Symposium 01: Novel Immunogen, Adjuvant and Vaccine Delivery
Strategies
• Wyatt, Scheif, Hanke, Garçon
• Symposium 06: Recent Advances in B cell and Protective Antibody
Responses
• Diskin, Morris, Haynes, Walker, Wu
• Symposium 09: Potential Role for Binding/ADCC Antibodies in
Protection Against HIV Acquisition
• Nimmerjahn, Hessell, Alter, Forthal, Tiemessen
– Oral Abstracts
– Oral Abstract 01: Novel Immunogens and Inserts
– Oral Abstract 05: Novel Monoclonals and Structural Insight
– Oral Abstract 10: B Cell Vaccine Concepts
• T-cell immunity – killer T-cells
• Bette Korber
• Andrew McMichael
• Rafick-Pierre Sekaly
– Symposia
• Symposium 01: Novel Immunogen, Adjuvant and Vaccine
Delivery Strategies
• Wyatt, Scheif, Hanke, Garçon
• Symposium 07: Systems Biology in HIV Vaccine Research
• Katze, Shen-Orr, Pulendran, Haining
– Oral Abstracts
– Oral Abstract 01: Novel Immunogens and Inserts
– Oral Abstract 02: T-cell Immunity and Immune Escape
• Innate immunity
• Ashley Haase
• Rafick-Pierre Sekaly
– Symposia
• Symposium 05: Linking Innate Adaptive Immunity and
the Role of Host Genetics
• Telenti, Harty, Brooks, Brenchley, Luban
– Oral Abstracts
– Oral Abstract 08: Innate and Mucosal Immunity
• Early Clinical Trials
• Guiseppe Pantaleo
• Larry Corey
• Seth Berkley
– Symposia
• Symposium 02: Early Phase Clinical Trials
• Vasan, Sandström, Shao, Barouch
– Oral Abstracts
– Oral Abstract 06: Pre-Clinical and Early Clinical Trials
• Advanced Clinical Trials
• Nelson Michael
• Larry Corey
– Symposia
• Symposium 08: Bridging and Sustaining Community
Partners in the Evolving Search for an AIDS Vaccine
• Frew, Thaitawat, Bekker, Calazans/Warren
– Oral Abstracts
– Oral Abstract 03: Results and Insights from Advanced
Clinical Trial
• Interface of PreP/Microbicides and Vaccines
• Salim Karim
– Symposia
• Round Table Discussion: Integrating Prevention Results
Into HIV Vaccine Trials
• McGowan, Self, Philpott, Rose
– Oral Abstracts
– Oral Abstract 07: Prevention Strategies
• Hot Topics for 2010
– New broadly neutralizing monoclonal antibodies
– Thai Trial (RV144) update on correlates of protection
– Non-neutralizing antibody inhibition of infection
– Novel T- and B-cell immunogens – mosaics vs
conserved, constrained vs scaffold
– Next generation vaccine vectors
– Impact, positive and negative, of biomedical
prevention on vaccine clinical trials
– Systems Biology approaches to dissecting the immune
response – role of innate immunity